• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Small Cell Lung Cancer

The AJMC® Lung Cancer compendium is a comprehensive resource for clinical news and expert insights for the condition.

Latest News

Baseline LDH and tumor burden, not drug exposure, remain the dominant predictors of survival in ES-SCLC. | Image credit: appledesign - stock.adobe.com
Fixed-Dose Serplulimab Strategy Supported by Comprehensive Pharmacokinetic Analysis

October 30th 2025

A new population pharmacokinetic and exposure-response analyses shows no added efficacy or safety benefit from higher doses of serplulimab.

The data suggests immunochemotherapy generates improved response rates and may prolong survival. | Image credit: Ivelin Radkov - stock.adobe.com
Neoaduvant Immunochemotherapy May Improve Outcomes in LS-SCLC

October 29th 2025

The authors say more research is warranted to identify novel therapies that improve response and disease control in patients with ES-SCLC in the third line. | Image credit: Crystal light - stock.adobe.com
Real-World Outcomes From Third-Line SCLC Treatment Show Need for More Options

October 24th 2025

The study suggests that LAG-3 is worthy of further investigation in small cell lung cancer. | Image credit: Sebastian Kaulitzki - stock.adobe.com
LAG-3 May Be Key SCLC Biomarker

October 22nd 2025

Combining CAR T cells with first-line therapies like immune checkpoint inhibitors may ultimately prove to be the best method of deployment for CAR T in SCLC. | Image credit: Alpha Tauri 3D - stock.adobe.com
CAR T-Cell Therapy Holds Potential in SCLC, but Significant Barriers Remain

October 8th 2025

Latest CME Events & Activities

Advancing Immunotherapy in Endometrial Cancer: A Managed Care Perspective on Personalized Care

1.5 Credits / Gynecologic Cancer, Health Equity, Diversity & Inclusion, Oncology, Women's Health

View More

Updated Guidance and Managed Care Strategies to Optimize Care in EGFR Mutated NSCLC

2.0 Credits / Lung Cancer, Oncology, Pulmonology/Respiratory

View More

Payment for Pharmacist Services: 2025 Update

1.0 Credit / General Pharmacy, Health Equity, Diversity & Inclusion, Law

View More

An American Journal of Managed Care Forum: Bridging Evidence and Access in Advanced Small Cell Lung Cancer

1.5 Credit / Lung Cancer, Oncology, Pulmonology

View More

<1
...
7891011
© 2026 MJH Life Sciences
AJMC®
All rights reserved.